Acquisition by Sim Brandon of tradable shares of Cardio Diagnostics subject to Rule 16b-3

CDIOW Stock  USD 0.03  0.01  23.08%   
Slightly above 59% of Cardio Diagnostics' investor base is looking to short. The analysis of the overall investor sentiment regarding Cardio Diagnostics Holdings suggests that many traders are alarmed. Cardio Diagnostics' investing sentiment can be driven by a variety of factors including economic data, Cardio Diagnostics' earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Cardio Diagnostics Holdings Director. Grant, award or other acquisition pursuant to Rule 16b-3

Read at macroaxis.com
Cardio insider trading alert for acquisition of restricted stock units by Sim Brandon, Director, on 21st of June 2024. This event was filed by Cardio Diagnostics Holdings with SEC on 2023-06-30. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Cardio Diagnostics' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Cardio Diagnostics' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Cardio Diagnostics Fundamental Analysis

We analyze Cardio Diagnostics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cardio Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cardio Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Total Asset

Total Asset Comparative Analysis

Cardio Diagnostics is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Cardio Diagnostics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cardio Diagnostics stock to make a market-neutral strategy. Peer analysis of Cardio Diagnostics could also be used in its relative valuation, which is a method of valuing Cardio Diagnostics by comparing valuation metrics with similar companies.

Additional Tools for Cardio Stock Analysis

When running Cardio Diagnostics' price analysis, check to measure Cardio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardio Diagnostics is operating at the current time. Most of Cardio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Cardio Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardio Diagnostics' price. Additionally, you may evaluate how the addition of Cardio Diagnostics to your portfolios can decrease your overall portfolio volatility.